Abstract: A nasal interface apparatus is provided for delivering a gas to a human via a gas supply tube and a pair of tubular nasal inserts. The apparatus includes a manifold hollow body defining an internal chamber, an inlet for fluid communication from the gas supply tube into the internal chamber, an outlet for fluid communication between the internal chamber and the pair of nasal inserts, and an air entrainment port for fluid communication between the internal chamber and a space external to the hollow body. The apparatus also includes a valve member movable relative to the hollow body for varying the size of the open area of the air entrainment port. The open area of the air entrainment port may be varied to regulate a pressure signal detected by a pulse-flow oxygen concentrator (POC).

Abstract: A low-power Hall thruster gains significantly improved efficiency by a combination of features, including a single piece, h-shaped magnetic screen which enables a more efficient internal volume utilization as well as optimal magnetic shielding; an internally mounted cathode with varying diameter further decreases the footprint of the thruster; an anode with multiple baffles connected by axially oriented holes generates a highly azimuthally uniform propellant flow.

Abstract: A low-power Hall thruster gains significantly improved efficiency by a combination of features, including a single piece, h-shaped magnetic screen which enables a more efficient internal volume utilization as well as optimal magnetic shielding; an internally mounted cathode with varying diameter further decreases the footprint of the thruster; an anode with multiple baffles connected by axially oriented holes generates a highly azimuthally uniform propellant flow.

Abstract: A low-power Hall thruster gains significantly improved efficiency by a combination of features, including a single piece, h-shaped magnetic screen which enables a more efficient internal volume utilization as well as optimal magnetic shielding; an internally mounted cathode with varying diameter further decreases the footprint of the thruster; an anode with multiple baffles connected by axially oriented holes generates a highly azimuthally uniform propellant flow.

Abstract: A Hall thruster is configured to reduce or eliminate pole erosion by electrically tying the cathode to the thruster chassis body. The electrical connection controls the ion energy hence reducing erosion at the pole. In a different configuration, the cathode is biased by a power supply, allowing further control of the ion energy and the elimination of pole erosion, thus increasing the thruster's operational lifetime.

Abstract: A low-power Hall thruster gains significantly improved efficiency by a combination of features, including a single piece, h-shaped magnetic screen which enables a more efficient internal volume utilization as well as optimal magnetic shielding; an internally mounted cathode with varying diameter further decreases the footprint of the thruster; an anode with multiple baffles connected by axially oriented holes generates a highly azimuthally uniform propellant flow.

Abstract: A Hall thruster is configured to reduce or eliminate pole erosion by electrically tying the cathode to the thruster chassis body. The electrical connection controls the ion energy hence reducing erosion at the pole. In a different configuration, the cathode is biased by a power supply, allowing further control of the ion energy and the elimination of pole erosion, thus increasing the thruster's operational lifetime.

Abstract: A portable vehicle safe and method for installing the safe in a vehicle is disclosed. The save can be mounted in a vehicle in any orientation while still providing convenient access to the contents. A generally rectangular body of the safe features a door that is mounted at an angle so that the safe can be mounted both vertically and horizontally. In particular, the vehicle safe can be mounted in a concealed location, for example, under a seat or in a console or glove box of a vehicle while still allowing easy and discreet access from inside the vehicle. Although the invention is shown and described in connection with storing a firearm, the vehicle safe can be used to store any desired item or items.

Abstract: The invention relates to a gaseous composition containing an active gaseous compound selected from the group made up of Xe and Ar to be used for preventing or minimising an ischaemia-reperfusion lesion of a biological material in a donor patient, while and/or immediately after taking a sample of said biological material from said donor patient, said gaseous composition being administered to the donor patient prior to taking the sample of biological material from said donor patient.

Abstract: The invention relates to a gaseous composition containing argon as an active gaseous compound for use to prevent or minimize an ischaemia-reperfusion lesion of a biological material in a recipient individual, during and/or subsequent to the transplantation of said biological material in said recipient individual, wherein said gaseous composition is administered to the recipient individual prior to, during and/or subsequent to the surgical operation aimed at grafting the biological material in said recipient individual.

Abstract: A portable vehicle safe and method for installing the safe in a vehicle is disclosed. The save can be mounted in a vehicle in any orientation while still providing convenient access to the contents. A generally rectangular body of the safe features a door that is mounted at an angle so that the safe can be mounted both vertically and horizontally. In particular, the vehicle safe can be mounted in a concealed location, for example, under a seat or in a console or glove box of a vehicle while still allowing easy and discreet access from inside the vehicle. Although the invention is shown and described in connection with storing a firearm, the vehicle safe can be used to store any desired item or items.

Abstract: The disclosure describes a technique for monitoring patient utilization of inhaled Nitric Oxide as well as waste exhaust of Nitric Oxide in gases exhaled from patient lungs. By monitoring the real dose provided to a patient, actual compliance with therapeutic target doses may be monitored to improve patient safety and therapeutic benefit from inhaled Nitric Oxide. Simultaneously, unnecessary waste of inhaled Nitric Oxide may be avoided thereby increasing the cost effectiveness of Nitric Oxide therapy. The minimization of Nitric Oxide waste has the further benefit of reducing environmental Nitrogen Dioxide levels in e.g. a NICU environment thereby mitigating medical personnel's Nitrogen Dioxide exposure.

Abstract: The disclosure describes a technique for monitoring patient utilization of inhaled Nitric Oxide as well as waste exhaust of Nitric Oxide in gases exhaled from patient lungs. By monitoring the real dose provided to a patient, actual compliance with therapeutic target doses may be monitored to improve patient safety and therapeutic benefit from inhaled Nitric Oxide. Simultaneously, unnecessary waste of inhaled Nitric Oxide may be avoided thereby increasing the cost effectiveness of Nitric Oxide therapy. The minimization of Nitric Oxide waste has the further benefit of reducing environmental Nitrogen Dioxide levels in e.g. a NICU environment thereby mitigating medical personnel's Nitrogen Dioxide exposure.

Abstract: The disclosure describes a technique for monitoring patient utilization of inhaled Nitric Oxide as well as waste exhaust of Nitric Oxide in gases exhaled from patient lungs. By monitoring the real dose provided to a patient, actual compliance with therapeutic target doses may be monitored to improve patient safety and therapeutic benefit from inhaled Nitric Oxide. Simultaneously, unnecessary waste of inhaled Nitric Oxide may be avoided thereby increasing the cost effectiveness of Nitric Oxide therapy. The minimization of Nitric Oxide waste has the further benefit of reducing environmental Nitrogen Dioxide levels in e.g. a NICU environment thereby mitigating medical personnel's Nitrogen Dioxide exposure.

Abstract: The disclosure describes a technique for monitoring patient utilization of inhaled Nitric Oxide as well as waste exhaust of Nitric Oxide in gases exhaled from patient lungs. By monitoring the real dose provided to a patient, actual compliance with therapeutic target doses may be monitored to improve patient safety and therapeutic benefit from inhaled Nitric Oxide. Simultaneously, unnecessary waste of inhaled Nitric Oxide may be avoided thereby increasing the cost effectiveness of Nitric Oxide therapy. The minimization of Nitric Oxide waste has the further benefit of reducing environmental Nitrogen Dioxide levels in e.g. a NICU environment thereby mitigating medical personnel's Nitrogen Dioxide exposure.

Abstract: The disclosure describes a technique for monitoring patient utilization of inhaled Nitric Oxide as well as waste exhaust of Nitric Oxide in gases exhaled from patient lungs. By monitoring the real dose provided to a patient, actual compliance with therapeutic target doses may be monitored to improve patient safety and therapeutic benefit from inhaled Nitric Oxide. Simultaneously, unnecessary waste of inhaled Nitric Oxide may be avoided thereby increasing the cost effectiveness of Nitric Oxide therapy. The minimization of Nitric Oxide waste has the further benefit of reducing environmental Nitric Oxide and Nitrogen Dioxide levels in e.g. a NICU environment thereby mitigating medical personnel's Nitric Oxide and Nitrogen Dioxide exposure.

Abstract: A method for designing and/or customizing the treatment or for treating by inhalation of a patient suffering from a respiratory or non-respiratory disease including the steps of presenting a patient suffering from the disease; determining the kind of disease of the patient; prescribing at least one drug and/or gas and at least one kind of device to be used for administrating the drug or gas; inputting into a processing element, data chosen among the drug and/or prescribed gas and drug particle size obtained with the prescribed device; inputting into the processing element at least one patient characteristics of the patient; inputting into processing element at least one morphology and/or ventilatory condition of the patient; running a code in the processing element using the input data and conditions thereby calculating a flow and/or deposition characteristics customized to the patient.

Abstract: A charging control device for use with a spacecraft solar array employs a field emitter array including a cathode and an anode; a first resistor coupled between the cathode of the field emitter array and a solar array common; and a second resistor coupled between the anode of the field emitter array and a solar array positive.

Abstract: Described are the uses of benzyl formate having the structure: ##STR1## and d-pulegone having the structure: ##STR2## taken alone or taken in combination as attractants for beetles (Coleoptera). The benzyl formate and d-pulegone taken along or in combination find utility primarily as bait enhancers for acute toxins and/or trapping devices.